Tuberculosis risk with biologics by screening-guided preventive strategy in rheumatoid arthritis under intermediate tuberculosis burden.

Anna ShinYun Jong LeeEun Bong Lee Eunyoung Emily Lee Seoyoung C Kim Eun Ha Kang

Published in: Rheumatology (Oxford, England) (2021)

This population-based cohort study warns that the current screening-based preventive strategy generates a substantially higher TB risk after biologics initiation among screening-negative patients compared with screening-positive patients receiving chemoprophylaxis, when the background TB burden is not low.

Keyphrases

mycobacterium tuberculosis
rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
pulmonary tuberculosis
emergency department
risk factors
hiv aids
prognostic factors
systemic lupus erythematosus
peritoneal dialysis
systemic sclerosis
hiv infected
idiopathic pulmonary fibrosis